From cancer medication to antibiotic

- EN - DE
PhD-student Robert Macsics examining an agar plate on which colonies of the Stap
PhD-student Robert Macsics examining an agar plate on which colonies of the Staphylococcus aureus bacteria have grown. The color change of the plate from red to yellow in the area of the bacterial colonies indicates that they are bacteria of the species S. aureus. Image: Andreas Heddergott / TUM
Modified cancer drug effective against multi-resistant bacteria

Antibiotic-resistant bacteria are increasingly the source of deadly infections. A team of scientists from the Technical University of Munich (TUM) and the Helmholtz Center for Infection Research (HZI) in Braunschweig have now modified an approved cancer drug to develop an active agent against multidrug-resistant pathogens.

The methicillin-resistant Staphylococcus aureus (MRSA) is the source of severe and persistent infections. Some strains are even resistant to multiple antibiotics. There is consequently an urgent need for new drugs effective against MRSA infections.

"The industrial development of new antibiotics is stalling and not keeping pace with the spread of antibiotic resistance. ...
account creation

TO READ THIS ARTICLE, CREATE YOUR ACCOUNT

And extend your reading, free of charge and with no commitment.

Register


Login


Subscribe